BillionToOne is a next-generation molecular diagnostics company dedicated to developing powerful and accurate diagnostic tests that are accessible to all. Our innovative QCT molecular counting technology significantly enhances the resolution of disease detection using cell-free DNA by over a thousandfold. This groundbreaking technology is integral to our product offerings, including one of our flagship products, Unity Complete™, the only non-invasive prenatal screen capable of assessing fetal risk for both common recessive conditions and aneuploidies from a single maternal blood sample. Leveraging the same molecular counting technology, we've expanded our impact into oncology in 2023 with a pioneering liquid biopsy test, Northstar, that combines treatment selection with monitoring. To date, over 500,000 patients have benefited from our innovative and precise diagnostic tests, and our Annual Recurring Revenue (ARR) has grown from $0 to $125 million in the last ~4 years.

BillionToOne has successfully raised close to $400 million in funding, with a notable $130 million Series D round completed in June 2024, resulting in a company valuation of over $1 billion. This funding has come from prestigious global institutional investors, including Hummingbird, Adams Street Partners, Neuberger Berman, Baillie Gifford, and Premji Invest. BillionToOne has recently been recognized by Forbes as one of America's Best Startup Employers for 2024, highlighting the company's exceptional work environment and commitment to innovation.

Our team has grown significantly and we now proudly employ over 400 highly skilled individuals. Despite substantial growth, we have successfully maintained the unique culture that has defined BillionToOne from inception, continuing to cultivate a team that is not only diverse and passionate but also innovative. Headquartered in Menlo Park, California, with an additional facility in Union City, California, BillionToOne remains at the forefront of significant advances in molecular diagnostics, evidenced by the recent announcement of clinical outcomes data for its Unity Fetal Risk Screen and new advancements in cancer diagnostics. For more detailed information about BillionToOne and its groundbreaking work, please visit our website at www.billiontoone.com.

We are looking for a field-based professional Medical Science Liaison (MSL), Oncology with scientific and clinical expertise in oncology to support our oncology portfolio of liquid biopsy products. The Medical Science Liaison (MSL), Oncology is a remote position and reports to our Associate Director, Medical Affairs.

Region: US Central or Eastern Time Zones preferred

Responsibilities:

• Serve as a key liaison to Health Care Providers (HCPs) in the oncology space regarding liquid biopsy and BillionToOne products
• Serve as a key member of the BillionToOne Oncology Medical Affairs team
• Develop and maintain relationships with key opinion leaders (KOLs) by engaging in scientific exchange with medical and scientific partners
• Support commercial team by providing impactful information that enhances the value and proper use of BillionToOne products
• Respond to HCP customer inquiries to provide focused and balanced clinical and scientific information that supports the appropriate use of or clinically differentiates BillionToOne's products and services
• Contribute to development of provider and patient educational products
• Adhere to internal standard processes and comply with regulatory and compliance requirements
• Other duties as may be assigned

Requirements:

• Advanced degree in a related science or health discipline
• 2+ years of experience as a Medical Science Liaison or similar position in oncology, diagnostic experience preferred
• Expertise in discussing scientific content and context to multiple audiences
• Excellent communication and interpersonal skills
• Ability to travel up to 70%

Benefits And Perks:

• Working with a team of ‘rockstars’ who bring out the best in everyone
• Open, transparent culture that includes weekly Town Hall meetings
• The ability to indirectly or directly change the lives of hundreds of thousand patients
• Multiple medical benefit options; employee premiums paid 100% of select plans, dependents covered at 80%
• Extremely generous Family Bonding Leave for new parents (16 weeks, paid at 100%)
• Retirement savings program including a 4% Company match
• Free daily on-site lunches provided from top eateries
• Latest and greatest hardware (laptop, lab equipment, facilities)
• A variety of perks on campus (state of the art gym, restaurant)
• Free on-site EV charging (compatible with all EVs, including Tesla)

At BillionToOne, we are proud to offer a combination of a (1) base pay range (actual amount offered is based experience and salary/equity options split that the candidate chooses) (2) generous equity options offering, on top of (3) industry leading company benefits (free healthcare options, 401k match, very generous fully paid parental leave etc.).

For this position, we offer a total compensation package of $220,000, including a base pay range of $180,000-$200,000 per year.

BillionToOne is an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.